Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score–matching analysis

[1] Zhu N(2020)China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 382 727-733

[2] Zhang D(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet. 395 1054-1062

[3] Wang W(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia inWuhan, China: a descriptive study Lancet 395 507-513

[4] Zhou F(2005)Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome J Chin Med Assoc 68 4-10

[5] Yu T(2019)Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score Front Microbiol 10 2752-416

[6] Du R(2013)Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis BMJ 347 f5061-2610

[7] Chen N(2014)Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai Clin Respir J 8 410-732

[8] Zhou M(2020)Hypertension: An immune related disorder? Clin Immunol 212 108247-92

[9] Dong X(2005)Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 Circulation 111 2605-942

[10] Chen CY(2020)Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia Emerg Microbes Infect 9 727-undefined

[1] Zhu N(2020)China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 382 727-733

[2] Zhang D(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet. 395 1054-1062

[3] Wang W(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia inWuhan, China: a descriptive study Lancet 395 507-513

[4] Zhou F(2005)Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome J Chin Med Assoc 68 4-10

[5] Yu T(2019)Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score Front Microbiol 10 2752-416

[6] Du R(2013)Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis BMJ 347 f5061-2610

[7] Chen N(2014)Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai Clin Respir J 8 410-732

[8] Zhou M(2020)Hypertension: An immune related disorder? Clin Immunol 212 108247-92

[9] Dong X(2005)Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 Circulation 111 2605-942

[10] Chen CY(2020)Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia Emerg Microbes Infect 9 727-undefined